Asian stocks gain on stronger Chinese factory data
Asian stocks are higher after Chinese manufacturing improved, South Korea reported stronger exports and Australia’s central bank left its benchmark lending rate at a record low
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Asian stocks rose Tuesday after Chinese manufacturing improved, South Korea reported stronger exports and Australia's central bank left its benchmark lending rate at a record low.
Markets in Shanghai, Tokyo, Hong Kong and Sydney advanced as investors looked ahead to U.S. Federal Reserve Chairman Jerome Powell’s appearance before legislators a day after he said the pace of recovery is moderating.
Wall Street’s benchmark S&P 500 index closed down 0.5% overnight but ended November up 10.8% for its biggest monthly gain since April.
Investors are optimistic about the development of a possible coronavirus vaccine despite caution about the short-term economic impact of rising virus cases in the United States and Europe.
The future “seems incredibly bright and bullish,” Stephen Innes of Axi said in a report.
The Shanghai Composite Index gained 1.3% to 3,434.37 after an index of Chinese manufacturing activity by a business magazine, Caixin, hit a decade high in November. A separate survey Monday by the government statistics agency showed activity at a three-year high.
The Nikkei 225 in Tokyo advanced 1.2% to 26,750.43.
The Hang Seng in Hong Kong added 0.9% to 26,590.04 after the Chinese territory on Monday announced the closure of government offices and restrictions on restaurants and other businesses to stop a new spike in coronavirus infections.
The Kospi in Seoul advanced 1.8% to 2,637.55 after South Korea reported exports rose 4% in November over a year earlier, rebounding from October's decline. That was led by a 16.4% increase for semiconductor sales.
The S&P-ASX 200 in Sydney rose 1.1% to 6,588.50 after Australia’s central bank left its benchmark lending rate unchanged at 0.1%. The bank said an economic recovery is under way but is likely to be “uneven and drawn out.”
India's Sensex opened up 0.9% at 44,524.36. New Zealand declined while Southeast Asian markets rose.
In Washington, Powell said in a statement Monday that economic prospects are “extraordinarily uncertain” after the pace of improvement moderated. He said a full recovery is unlikely until the public is confident the disease is under control.
Powell was due to appear Tuesday before the Senate Banking Committee with Treasury Secretary Steven Mnuchin. The panel oversees the $2 trillion aid package approved by Congress in March.
On Monday, the S&P 500 declined to 3,621.63. The Dow Jones Industrial Average lost 0.9% to 29,638.64. The Nasdaq composite slipped 0.1% to 12,198.74.
The slide followed reports showing the pandemic dragging down U.S. economic activity in the near future. But investors appear to be looking beyond that.
Investors are encouraged by the end of uncertainty about the outcome of the U.S. presidential election. They are reassured Washington will be under divided control, reducing the chances of big changes in taxes or regulation.
Markets also have been heartened by announcements from pharmaceutical companies of advances in vaccine development.
One developer, Moderna, said Monday it is ready to apply for emergency approval in the United States and Britain. Pfizer and German partner BioNTech are asking to begin vaccinations in the U.S. in December. British regulators also are assessing the Pfizer shot and another from AstraZeneca.
In energy markets, benchmark U.S. crude oil lost 32 cents to $45.03 per barrel in electronic trading on the New York Mercantile Exchange. The contract fell 19 cents to $45.34 on Monday. Brent crude, used to price international oils, sank 32 cents to $47.56 per barrel in London. It dropped 59 cents from the previous session to $47.59.
The dollar edged up to 104.38 yen from Monday’s 104.34 yen. The euro advanced to $1.1960 from $1.1946.